Return to Article Details The future of cancer immunotherapy: Advances in checkpoint inhibitors and chimeric antigen receptor-T cells discussing recent progress in immunotherapy for cancer, focusing on checkpoint inhibitors and chimeric antigen receptor-T cell therapies Download Download PDF